Explore more Johnson & Johnson sites:
Share
Back to top
Maternal and child health
-
For Pregnancy and Infant Loss Awareness Month, learn how one woman advocated for herself and fought to complete her family after she was diagnosed with hemolytic disease of the fetus and newborn—and why Johnson & Johnson is committed to finding a better treatment for this rare and deadly blood disorder.
-
Learn how the world's largest and most broadly based healthcare company has been empowering female employees, scientists and leaders—and improving the well-being of mothers around the world—since its founding 137 years ago.
-
ON NOW
What to Know About HDFN—a Serious Blood Disorder in Babies—Including a Possible New Treatment
Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That's why Johnson & Johnson is passionate about investigating a promising option for treating the disorder. -
It was an historic initiative: train healthcare workers across China in neonatal resuscitation. We go behind the scenes to explore the secrets of the program’s success.
